﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Public And Global Health</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Public And Global Health"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364371v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.30.26364359v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.01.26364341v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.10.01.26364489v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.30.26364355v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.26.26364071v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364307v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364291v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364320v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364109v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364272v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364306v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364317v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26361644v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.28.26364154v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.28.26364096v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.22.26363661v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.29.26364257v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26362980v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26363779v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.24.26363961v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.25.26363991v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.24.26363829v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.22.26363747v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26363828v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26363803v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.23.26363810v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.22.26363685v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.21.26363552v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.09.21.26363549v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364371v1?rss=1">
<title>
<![CDATA[
Diabetes testing, care cascade and the burden of undiagnosed diabetes in Kenya. Evidence from the 2015 Kenya STEPwise survey. 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364371v1?rss=1
</link>
<description><![CDATA[
Background: Diabetes is a growing public health challenge globally, with a disproportionate burden occurring in low- and middle-income countries (LMICs). In Kenya, limited evidence exists on type 2 diabetes mellitus (T2DM) screening coverage, undiagnosed diabetes, and progression through the diabetes care cascade. This study assessed the prevalence and determinants of T2DM testing, quantified undiagnosed T2DM, and examined the T2DM care cascade in Kenya. Methods: We analysed data from the 2015 Kenya WHO STEPwise survey, a nationally representative cross-sectional survey of adults aged 18-69 years. The analysis included 4,167 participants after excluding individuals with missing fasting plasma glucose (FPG) measurements and those below the age of 18 and above 69 years. Diabetes testing was defined as self-reported prior blood glucose measurement by a health worker among individuals without known diabetes. Diabetes was defined as FPG [&ge;]7 mmol/L, previous diagnosis, or current diabetes treatment. Weighted prevalence estimates with 95% confidence intervals (CI) were calculated. Univariable and multivariable logistic regression analyses were conducted to identify factors associated with diabetes screening while accounting for the complex survey design. Results: Overall, 11.9% (95% CI: 9.7-14.5) of participants reported ever being tested for diabetes. The weighted prevalence of diabetes was 2.66% (95% CI: 2.06-3.42), while 53.4% (95% CI: 39.0-67.4) of diabetes cases were previously undiagnosed. Testing prevalence was highest among older adults, individuals with tertiary education, obese participants, and those with hypertension, but lowest among younger adults, individuals with no formal education, and residents of the North Eastern region. Among individuals with diabetes, 46.9% were aware of their diagnosis, 40.8% of those aware were on treatment, and only 26.4% of those on treatment had achieved glycaemic control. In multivariable analysis, older age (60-69 years: aOR=6.29, 95% CI: 3.66-10.79), tertiary education (aOR=2.65, 95% CI: 1.33-5.27), poorest wealth quintile (aOR=8.42, 95% CI: 4.11-17.24), obesity (aOR=2.13, 95% CI: 1.41-3.21), and hypertension (aOR=1.64, 95% CI: 1.21-2.23) were significantly associated with increased odds of diabetes testing. Conclusion: Diabetes testing coverage in Kenya remains low, with more than half of diabetes cases remaining undiagnosed and substantial losses occurring across the diabetes care cascade. These findings highlight critical gaps in early diagnosis, linkage to care, treatment uptake, and glycaemic control. Strengthening integrated diabetes screening and care services, particularly for underserved and high-risk populations, is essential to improve early detection and continuity of care in Kenya.
]]></description>
<dc:creator><![CDATA[ Akoth, C., Thomas, C. V., Oguta, J. O., Wambiya, E. O. A., Dodd, P. J. ]]></dc:creator>
<dc:date>2026-10-02</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364371</dc:identifier>
<dc:title><![CDATA[Diabetes testing, care cascade and the burden of undiagnosed diabetes in Kenya. Evidence from the 2015 Kenya STEPwise survey.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.30.26364359v1?rss=1">
<title>
<![CDATA[
Proof-of-implementation of the SMART2D intervention: findings from a cluster randomised feasibility trial for prevention and control of type 2 diabetes in socio-economically disadvantaged neighbourhoods in Stockholm, Sweden 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.30.26364359v1?rss=1
</link>
<description><![CDATA[
Background Type 2 diabetes (T2D) disproportionately affects socioeconomically disadvantaged communities. Evidence on the feasibility and effectiveness of prevention and self-management strategies in complex contexts remains limited. Objective To report effectiveness outcomes from a feasibility trial comparing the SMART2D intervention with routine primary care for T2D prevention and control in two neighbourhoods in Stockholm. Methods A cluster-randomized feasibility trial with hybrid type 1 design was conducted in two neighbourhoods among individuals at high risk of T2D (n=84) or with diagnosed T2D (n=58), allocated to an integrated care arm (n=70; personal coaching and community outreach) or facility-only arm (n=72; routine care). Primary outcomes were glycaemic control (participants with T2D) and HbA1c reduction (participants at high risk of T2D); secondary outcomes were retention to care and diabetes incidence (participants at high risk of T2D). Analysis used intention-to-treat principles: difference-in-differences with mixed-effects models for HbA1c reduction, and modified Poisson regression (IRR, 95% CI) for other outcomes. Results Among participants with T2D, glycaemic control (adjusted IRR=0.92, 95% CI=0.89-0.95) and retention to care (adjusted IRR=0.91, 95% CI=0.91-0.92) were significantly lower in the integrated care arm. Among participants at high risk of T2D, integrated care showed a marginally significant, greater HbA1c reduction (adjusted 2.02, 0.20-3.84) and significantly higher retention to care (adjusted IRR=1.22, 1.15-1.29), plus fewer incident diabetes cases (0 vs. 2 in facility-only). Conclusions Integrated care (personal coaching, community outreach) benefited HbA1c reduction and retention among participants at high risk of T2D, whereas facility-only care improved glycaemic control and retention among participants with T2D.
]]></description>
<dc:creator><![CDATA[ Daivadanam, M., Sidney Annerstedt, K., Alveson, H., Timm, L., Johan Sundberg, C., Delobelle, P., Olmen, J. V., Absetz, P., Guwatudde, D. ]]></dc:creator>
<dc:date>2026-10-02</dc:date>
<dc:identifier>doi:10.64898/2026.09.30.26364359</dc:identifier>
<dc:title><![CDATA[Proof-of-implementation of the SMART2D intervention: findings from a cluster randomised feasibility trial for prevention and control of type 2 diabetes in socio-economically disadvantaged neighbourhoods in Stockholm, Sweden]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.01.26364341v1?rss=1">
<title>
<![CDATA[
The Antimicrobial Resistance Campaigns Reach and Community Engagement Evidence from Tanzania One Health Initiatives 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.01.26364341v1?rss=1
</link>
<description><![CDATA[
Objectives: Antimicrobial resistance (AMR) is no longer a future health problem but rather a present public health crisis. For over a decade, national AMR awareness initiatives have been undertaken in Tanzania to implement National Action Plans (NAPs). However, the assessment of whether these initiatives have reached the target population is still limited. This study evaluated physical reach, public perception and community participation in national AMR awareness campaigns in two regions in Tanzania. Methodology: This is a quantitative, community based, cross sectional study in Dar es Salaam and Mwanza regions, Tanzania. The multistage technique was used to sample 2,672 questionnaire respondents. Participant characteristics and perceptions of the campaign were summarised using descriptive statistics. Multivariable logistic and Firth regression were used to establish predictors of high AMR campaign perception and physical campaign reach. Results: Only 81 (3.03%) respondents reported being reached by AMR awareness physical campaigns. Physical reach was strongly linked with high education and skilled occupation. Respondents in Mwanza were less likely to be reached by campaigns compared to Dar es Salaam. Despite limited physical reach, the overall perception of the campaigns was positive. The majority of the respondents agreed on the importance of community involvement (91.6%), AMR education should be brought into schools (98.9%), believed the campaign messages were accurate (79.6%) and would like to get involved with future campaigns (91.4%). Higher odds for favourable perception were found to be independently associated with physical campaign reach (AOR=2.77, 95% CI: 1.40 to 5.49). Conclusions: The Promotion of AMR awareness campaigns in Tanzania seems to be well accepted by the public despite limited reach. Future campaigns need to shift away from one off activities and towards ongoing and inclusive community engagement, leveraging schools, community leaders, community based structures, and systematically tracking reach and behaviours.
]]></description>
<dc:creator><![CDATA[ Awami, R. R., Said, K., Kabuhaya, J., Swila, G., Ndunguru, G., Korosso, C., Munema, J., Mutashobya, M. S., Charles, S., Msagama, H. ]]></dc:creator>
<dc:date>2026-10-02</dc:date>
<dc:identifier>doi:10.64898/2026.10.01.26364341</dc:identifier>
<dc:title><![CDATA[The Antimicrobial Resistance Campaigns Reach and Community Engagement Evidence from Tanzania One Health Initiatives]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.10.01.26364489v1?rss=1">
<title>
<![CDATA[
Household contact management of drug-resistant tuberculosis: a global cost-effectiveness modelling analysis of expanded preventive treatment by age 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.10.01.26364489v1?rss=1
</link>
<description><![CDATA[
Background. Tuberculosis preventive treatment (TPT) with levofloxacin reduces tuberculosis disease incidence in multidrug-resistant or rifampicin-resistant (MDR/RR)-tuberculosis household contacts. However, with age, disease progression risk falls and the frequency of adverse events (AE) rises. Methods. To inform decision-makers, we evaluated the cost-effectiveness of expanding the use of MDR/RR-TPT by age, with and without tests of tuberculosis infection. We modelled MDR/RR-household contact management (HHCM) in 189 countries, incorporating age-dependent risks of disease progression, death and AEs. Incremental cost-effectiveness ratios were calculated as USD/disability-adjusted life year (DALY) averted, and as a fraction of per capita gross domestic product (GDP). Findings. Compared to baseline of MDR/RR-HHCM with TPT for those <15 years, adding TPT up to 45 years was cost-effective at a threshold of 30% GDP in 160/189 modelled countries including 17 of the 30 highest incidence countries. Of these 160 countries, the intervention was cost-saving in 46. Strategies targeting TPT to those testing positive for M. tuberculosis infection were dominated by those without testing. Globally, full use of MDR/RR-HHCM with TPT for all would avert 11,900 (10,400 to 13,800) episodes of tuberculosis, 9,960 (9,100 to 10,900) deaths, and 289,000 (262,000 to 321,000) DALYs, but would result in 71,000 (68,000 to 74,000) SAEs and cost $359 million (294 to 449). Interpretation. Expanding MDR/RR-TPT use to older ages without testing appears cost-effective in most settings, but may require substantial resources and result in large numbers of AEs. Funding. Unitaid
]]></description>
<dc:creator><![CDATA[ Mafirakureva, N., McQuaid, C. F., Harker, M., Garcia-Prats, A., Hesseling, A. C., Seddon, J. A., Dodd, P. ]]></dc:creator>
<dc:date>2026-10-02</dc:date>
<dc:identifier>doi:10.64898/2026.10.01.26364489</dc:identifier>
<dc:title><![CDATA[Household contact management of drug-resistant tuberculosis: a global cost-effectiveness modelling analysis of expanded preventive treatment by age]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.30.26364355v1?rss=1">
<title>
<![CDATA[
An Epidemiological Study of the Impact of Doula Care on Black Birth Outcomes in Baltimore, Maryland 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.30.26364355v1?rss=1
</link>
<description><![CDATA[
This study examines the impact of various maternal factors and continuous labor support on birth outcomes among 124 birthing people in the Baltimore region of Maryland who sought and/or received doula care. The cohort primarily consists of Black birthing people and includes detailed data on maternal age, race, education level, employment status, health insurance status, income level, preexisting health challenges, and pregnancy or delivery-related health challenges. The study also explores whether the pregnancy was the birthing person's first, as well as neonatal outcomes such as NICU admission, low birth weight, and other newborn health concerns. Due dates and delivery dates were compared and analyzed, where available, to provide a comprehensive understanding of the timing of births among the cohort. The findings highlight known correlations between maternal socioeconomic factors, health factors, and adverse birth outcomes, emphasizing the critical role of doula support during the prenatal period and labor and delivery in improving maternal and neonatal health, as well as in providing culturally competent care and positive birth experiences. This research contributes to the growing body of evidence on the benefits of doula care, particularly for marginalized communities, and underscores the need for targeted interventions to address health disparities among Black Birthing persons.
]]></description>
<dc:creator><![CDATA[ Watson, E. A. ]]></dc:creator>
<dc:date>2026-10-01</dc:date>
<dc:identifier>doi:10.64898/2026.09.30.26364355</dc:identifier>
<dc:title><![CDATA[An Epidemiological Study of the Impact of Doula Care on Black Birth Outcomes in Baltimore, Maryland]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.26.26364071v1?rss=1">
<title>
<![CDATA[
Perspectives from EPI personnel on immunization programme performance in Kenya: a thematic, complex adaptive systems and leverage-points analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.26.26364071v1?rss=1
</link>
<description><![CDATA[
Abstract Immunisation system performance depends on effective service delivery and the generation of high-quality data to support planning and decision-making. With the recent scaling down of external health funding, Kenya must identify sustainable strategies to strengthen the resilience of its immunisation programme. We conducted a three-part qualitative study comprising thematic analysis, application of complex adaptive systems (CAS) theory, and the Meadows leverage-points framework. Thematic key personnel interviews were conducted with selected Essential Programme on Immunisation (EPI) personnel from 14 counties and sub-counties in Kenya to explore factors influencing immunisation system performance. Vaccine distribution, health workforce shortages and immunisation financing emerged as the dominant themes affecting immunisation performance. Analysis through a CAS lens revealed that reinforcing feedback loops were more dominant than balancing loops, suggesting that system dysfunctions were more influential than adaptive self-correcting mechanisms, resulting in a tendency toward negative system behaviour. Application of the Meadows framework showed that existing interventions were largely concentrated at lower leverage levels, which are more likely to generate short-term operational improvements, while higher-leverage interventions with the potential for long-term system transformation remained underutilised. We concluded that systems-thinking approaches offer a powerful framework for understanding and improving immunisation system performance. They facilitate the identification of vulnerabilities and bottlenecks, while informing the design of higher-leverage interventions capable of producing sustainable and transformative improvements across the system.
]]></description>
<dc:creator><![CDATA[ Karanja-Chege, C. ]]></dc:creator>
<dc:date>2026-10-01</dc:date>
<dc:identifier>doi:10.64898/2026.09.26.26364071</dc:identifier>
<dc:title><![CDATA[Perspectives from EPI personnel on immunization programme performance in Kenya: a thematic, complex adaptive systems and leverage-points analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364307v1?rss=1">
<title>
<![CDATA[
Quantifying advances in infectious disease forecast skill across seasons and pathogens 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364307v1?rss=1
</link>
<description><![CDATA[
Infectious disease forecasting supports public health preparedness and response by informing resource allocation, intervention planning, and situational awareness. Infectious disease forecasting capabilities in the United States have grown over the past decade yet whether forecast quality has improved over this time remains unclear. Current evaluation metrics describe relative performance for a common set of forecast targets but cannot evaluate performance across different outcomes, seasons, and pathogens. We addressed this challenge by developing a novel skill score metric to assess forecasts based on performance relative to two benchmark models: a hindcast as an idealized upper bound of performance and a baseline model as a minimal performance standard. To study the impact of the baseline choice, we considered three types of baseline models with varying levels of complexity. Using this skill score framework, we retrospectively evaluated short-term influenza (influenza-like illness and hospitalization) and COVID-19 (case, death, and hospitalization) forecasts, focusing on how the performance of team and multi-model ensemble forecasts changed over time. The ensemble outperformed 99% of forecasts from a simplistic, naive baseline, and 84-91% of forecasts from more complex baseline models that incorporate recent data. We found consistent improvements in ensemble and team forecast skill over time for both influenza forecast targets, with 4-week horizon forecasts in the most recent year having higher skill scores than 1-week horizon forecasts in the first year of each challenge. Results were mixed for COVID-19 forecasts. This framework provides a comprehensive picture of progress in infectious disease forecasting over the past decade enabled by improved standardization, data, models, and collaboration.
]]></description>
<dc:creator><![CDATA[ Bay, C., Moghaddas, N. R., Davis, J. T., Borchering, R., Biggerstaff, M., Vespignani, A., Johansson, M. A. ]]></dc:creator>
<dc:date>2026-10-01</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364307</dc:identifier>
<dc:title><![CDATA[Quantifying advances in infectious disease forecast skill across seasons and pathogens]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364291v1?rss=1">
<title>
<![CDATA[
Health Insurance and Maternal Healthcare Utilisation in Nepal: Evidence from the Nepal Demographic and Health Survey 2022 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364291v1?rss=1
</link>
<description><![CDATA[
Background: Access to maternal healthcare services is essential for improving maternal and neonatal health outcomes. Health insurance can reduce financial barriers to healthcare access and may facilitate utilisation of maternal health services, and contextualized evidence can further support policy development and implementation. This study assessed the association between health insurance coverage and utilisation of antenatal care (ANC), institutional delivery, skilled birth attendance and postnatal care (PNC) services among women in Nepal. Methods: This study used data from the 2022 Nepal Demographic and Health Survey (NDHS), a nationally representative cross-sectional survey. The analysis included women aged 15-49 years who had a live birth within the 24 months preceding the survey. Inverse probability of treatment weighting (IPTW) based on propensity scores was applied to balance measured socioeconomic and demographic characteristics between insured and uninsured women. Weighted marginal structural models were used to estimate the association between health insurance coverage and maternal healthcare utilisation outcomes. Robustness was assessed using alternative propensity score specifications and E-values for unmeasured confounding. Results: Among 14,845 women interviewed, 2,078 reported a recent live birth and were included in the analysis (unweighted; 1,998 when survey-weighted). Of these, 201 (9.7%) had health insurance coverage and 1,877 (90.3%) were uninsured. After adjustment using IPTW, health insurance coverage was associated with significantly higher utilisation of maternal healthcare services. Insured women had more than twice the odds of attending at least four ANC visits compared with uninsured women (AOR 2.14; 95% CI 1.15-3.98). Similarly, insured women had higher odds of receiving a PNC check-up within two days of delivery (AOR 2.05; 95% CI 1.28-3.27) and receiving PNC from a skilled provider (AOR 1.94; 95% CI 1.23-3.06). Although insurance coverage was positively associated with institutional delivery (AOR 1.55; 95% CI 0.91-2.62) and skilled birth attendance (AOR 1.57; 95% CI 0.90-2.72), these associations did not reach statistical significance. Conclusion: Health insurance coverage was associated with greater utilisation of antenatal and postnatal healthcare services among women in Nepal. However, no significant association was observed for institutional delivery or skilled birth attendance. Expanding health insurance coverage, particularly among underserved populations, may help improve maternal healthcare utilisation and support progress towards universal health coverage and maternal health-related Sustainable Development Goals.
]]></description>
<dc:creator><![CDATA[ Lamsal, Y. R., Hussen, A. M., Browne, J. L., Sagtani, R. A. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364291</dc:identifier>
<dc:title><![CDATA[Health Insurance and Maternal Healthcare Utilisation in Nepal: Evidence from the Nepal Demographic and Health Survey 2022]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364320v1?rss=1">
<title>
<![CDATA[
Adults experiences of comorbid insomnia and pain: Entangled vicious cycle, driven by four primary factors 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364320v1?rss=1
</link>
<description><![CDATA[
Chronic pain and insomnia are common, each has serious consequences and they often coexist [1-5]. This novel study employed a phenomenological method to explore adults lived experiences of the core and meaning of comorbid insomnia and pain, here conceptualized as COMIP. The empirical data is based on 22 semi-structured interviews with adults with COMIP. Each interview was analysed, developing themes and analytical frameworks for all participants, which were then compared to construct one main analytical framework. The consolidated criteria for reporting qualitative research were used [6]. The essence of COMIP was: A vicious cycle of insomnia and pain driven by four intertwined primary factors with cross effects, which reduced sleep quality and quality of life. Four main themes emerged: Firstly, insomnia with hyperarousal like racing thoughts, and difficulties with finding comfortable sleeping positions due to pain, disturbed sleep and decreased sleep quality. Secondly, daytime symptoms like reduced energy, with reduced daytime function and reduced quality of life. Thirdly, 24-hour hyperarousal, stress and distressing experiences such as suffering. Finally, contextual factors like treatment reduced and/or increased COMIP. The main contribution of this research is three-fold; mapping of the experiences of living with COMIP, the conceptualization of COMIP, and introduction of novel concepts. Our findings indicate that, when evaluating patients with COMIP, there is value in exploring the four COMIP factors. Although, it varies between individuals which factor/s is central to their COMIP experience, we emphasize that COMIP is distressing, and patients are likely to need emotional support and validation. Keywords: COMIP, sleep, phenomenology, disability, rehabilitation, ICF.
]]></description>
<dc:creator><![CDATA[ Albertsdottir, A., Islind, A. S., Skuladottir, H., Halldorsdottir, S., Olafsdottir, K. A., Bjornsdottir, E., Vikingsson, A., Pires, G. N., Arnardottir, E. S. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364320</dc:identifier>
<dc:title><![CDATA[Adults experiences of comorbid insomnia and pain: Entangled vicious cycle, driven by four primary factors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364109v1?rss=1">
<title>
<![CDATA[
Discordance between source and point-of-use drinking-water Escherichia coli contamination in Bangladesh: a cross-sectional analysis and implications for safely managed water monitoring 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364109v1?rss=1
</link>
<description><![CDATA[
Background. Safely managed drinking-water monitoring under Sustainable Development Goal target 6.1 uses source-water quality, yet Escherichia coli is common in household drinking water in Bangladesh despite near-universal improved sources. We compared source and household point-of-use (POU) E. coli detection within households and estimated how the safely managed estimate changes if POU replaces source E. coli. Methods. Cross-sectional secondary analysis of the Bangladesh MICS 2025 water-quality subsample (February-June 2025; detection >=1 colony-forming unit/100 mL). We classified 5,944 households with readable paired results into four joint patterns and, exploratorily, examined POU detection among negative-source households and two-week diarrhoea in children under five with survey-weighted modified Poisson models. Results. E. coli was detected in 47.4% of source and 84.8% of POU samples; only 12.7% of households were negative at both. Among negative-source households, 75.8% had E. coli in household water, versus 94.7% with a detected source, persisting (33.3%) even direct from the source. The JMP-aligned safely managed estimate was 42.5% (95% CI 40.8-44.1); substituting POU for source E. coli gave 12.6% (11.4-13.8), not an SDG indicator estimate. The diarrhoea prevalence ratio for POU detection (1.04, 0.59-1.86) was too imprecise to interpret. In exploratory spatial analysis, POU detection clustered geographically (Moran's I 0.16 cluster level, 0.31 district level, both p<0.001) and was independently associated with lower elevation (odds ratio 0.62, 0.56-0.70) and longer travel time to healthcare (1.65, 1.29-2.12); five districts had complete detection among 84-94 households tested. Conclusions. Source and POU classifications differed substantially; the survey cannot show where or when contamination occurred. Contamination was spatially clustered, arguing against pure noise and pointing to districts for follow-up. The findings support evaluating standardised POU sampling as a complement to source-based monitoring, with targeted follow-up and cross-season, cross-country replication.
]]></description>
<dc:creator><![CDATA[ Hoque, S. M. A. U., Islam, M. K., Hasan, M. K., Banu, B., Hossain, Z. Z., Sharif, M. M., Baset, K. u. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364109</dc:identifier>
<dc:title><![CDATA[Discordance between source and point-of-use drinking-water Escherichia coli contamination in Bangladesh: a cross-sectional analysis and implications for safely managed water monitoring]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364272v1?rss=1">
<title>
<![CDATA[
Pilot Feasibility Study of a Community Health Worker-delivered Tobacco Cessation Intervention During Pregnancy: The Smoke-Free HOPE Randomized Controlled Trial 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364272v1?rss=1
</link>
<description><![CDATA[
Introduction: Tobacco use during pregnancy increases risks for adverse birth outcomes. In the US, tobacco use during pregnancy is associated with several poverty-related social determinants of health (fewer years of education, housing and food insecurity, substance abuse) that also contribute to adverse birth outcomes. In the Smoke-free Household and Parent (Smoke-free HOPE) pilot feasibility study, we designed and tested a theory-based intervention (socio-ecological framework) that leverages our group's ten years of experience enrolling and evaluating the largest maternal smoking cessation program in San Bernardino County. The Smoke-free HOPE intervention is delivered by community health workers (CHW) and integrates tobacco cessation support into the other support services that are typically offered during perinatal CHW visits. To our knowledge, this is the first US-based study to test a CHW-delivered prenatal tobacco cessation intervention. Methods: The Smoke-free HOPE intervention is a two-arm RCT that randomizes pregnant adults (n=32) who use tobacco products (combustible, e-cigarettes/vapes) to one of two CHW-delivered interventions: brief behavioral advice or patient navigation to community-based tobacco cessation services (i.e., state quitline). Both intervention arms were delivered during up to eight CHW visits (home, telehealth). Primary feasibility and acceptability outcomes are reported. Results: At baseline, we found that the predominant form of habitual tobacco use was e-cigarettes (53%) and that co-use of cannabis occurred in 69%. Two participants switched from cigarettes/cigars (blunts) to e-cigarettes during the trial. For feasibility, we met our recruitment and retention progression criteria by achieving the following: a county-based enrollment of four consenting participants per month, 87% initiating CHW support (i.e., dropout rate of <13%), and 66% completing all eight CHW visits. For post-intervention acceptability, 91% were very satisfied with the program, and 100% would recommend it to their peers. Post-intervention key informant interviews revealed that participants valued the trust, flexibility, and nonjudgmental support of CHW visits. Seventy-five percent [95% CI = 60% to 90%] set a quit date, and 50% [95% CI = 33% to 67%] achieved 30-day point-prevalence abstinence from nicotine. Conclusions: We have documented the feasibility and acceptability of a CHW-delivered intervention to provide cessation support for all major tobacco products used by pregnant adults in our community. Scaling the intervention to multiple sites will help us measure its efficacy.
]]></description>
<dc:creator><![CDATA[ Petersen, A. B., Rosas, B., Belliard, J., Tsoh, J., Gozalians, S., Quema, K., Oshiro, B., Yao, R., Singh, P. N. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364272</dc:identifier>
<dc:title><![CDATA[Pilot Feasibility Study of a Community Health Worker-delivered Tobacco Cessation Intervention During Pregnancy: The Smoke-Free HOPE Randomized Controlled Trial]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364306v1?rss=1">
<title>
<![CDATA[
Associations of Health Insurance, Household Income, and Cost-Related Healthcare Barriers With Routine Medical Checkup Utilization Among U.S. Adults: Evidence From the 2024 BRFSS 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364306v1?rss=1
</link>
<description><![CDATA[
Objective: To examine associations of health insurance status, household income, and cost-related healthcare barriers with receipt of a routine medical checkup among U.S. adults. Methods: This cross-sectional study analyzed 2024 Behavioral Risk Factor Surveillance System data. Survey-weighted descriptive estimates and multivariable logistic regression incorporated sampling weights, strata, and primary sampling units. The outcome was a routine medical checkup within the previous 12 months. Results: Among 321,592 complete cases, 78.0% of U.S. adults reported a recent routine checkup. Cost-related barriers (adjusted odds ratio [AOR], 0.56; 95% confidence interval [CI], 0.54-0.57) and uninsurance (AOR, 0.28; 95% CI, 0.27-0.29) were associated with lower checkup utilization. Lower household-income groups generally had lower adjusted odds than adults with incomes of $200,000 or more. Conclusions: Insurance, income, and reported cost barriers were independently associated with routine checkup utilization. Findings are descriptive and do not establish causal effects. Keywords: health insurance; household income; cost-related barriers; routine medical checkup; healthcare utilization; BRFSS
]]></description>
<dc:creator><![CDATA[ Onwuameze, C. N., Nwoha, J., Orji, G. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364306</dc:identifier>
<dc:title><![CDATA[Associations of Health Insurance, Household Income, and Cost-Related Healthcare Barriers With Routine Medical Checkup Utilization Among U.S. Adults: Evidence From the 2024 BRFSS]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364317v1?rss=1">
<title>
<![CDATA[
Understanding the acceptability of digital diabetes self-management tools among non-users: A qualitative study of personal, social and healthcare contexts 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364317v1?rss=1
</link>
<description><![CDATA[
Background: Diabetes poses a major global health and economic burden, and effective self management is essential for preventing complications. The National Health Service in England has recently announced plans to shift from analogue to digital services in their 10-year plan. However, digital health technology may also risk widening existing inequalities. MyWay Diabetes is a digital self-management intervention implemented in three regions across England. Understanding the acceptability of online and digital tools to support diabetes self-management, particularly among non users and underserved groups, is essential to ensure equitable engagement and implementation. Objectives: To (1) explore barriers to using online and digital support across diverse demographic groups with type 1 and type 2 diabetes who had not used the MyWay Diabetes platform, and (2) identify factors that could improve uptake and continued engagement. Design: Cross-sectional qualitative study. Methods: We conducted six focus groups with n=35 people living with diabetes (27F, 8M; 40% Asian British Pakistani) across three regions in England. The Theoretical Framework of Acceptability (TFA) informed data collection and analysis. Data were transcribed and analysed thematically using template analysis, mapped onto constructs of the TFA. Results: Digital engagement in diabetes self management was shaped by intersecting personal, social, and healthcare system factors. Participants' confidence with navigating digital environments was constrained by the emotional and practical burden of living with diabetes. Social and structural barriers, including cultural mismatch, accessibility challenges, financial constraints, and reliance on family further limited meaningful use of digital tools. Engagement was strongly influenced by trust in healthcare professionals and services; digital tools were considered acceptable when they complemented person-centred care, but resisted when perceived as replacing personalised, face to face support. Conclusions: Digital support for diabetes self management is more likely to be acceptable when it aligns with people's capabilities, social circumstances, and trusted healthcare relationships. Therefore, to prevent widening inequalities, digital tools should be accessible, culturally relevant, and embedded within supportive, person centred models of care. Lived Experience or Public Contribution: Public contributors with lived experience of diabetes (3F, 3M) reviewed participant materials and pseudonymised focus group transcripts, providing feedback on recruitment, data collection, and interpretation. Their insights informed analysis and theme development, ensuring a lived-experience perspective. Our public co-applicant is a co-author on this manuscript.
]]></description>
<dc:creator><![CDATA[ Hawkes, R. E., Osei-Kwasi, H., Taylor, D., Ashpole, D., Reiger, C. E., Amutike, D. M. A., Baxter, M., Bickerton, A., Cunningham, S. G., Wake, D. J., Willis, T., Rutter, M. K., Brooks, J. ]]></dc:creator>
<dc:date>2026-09-30</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364317</dc:identifier>
<dc:title><![CDATA[Understanding the acceptability of digital diabetes self-management tools among non-users: A qualitative study of personal, social and healthcare contexts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26361644v1?rss=1">
<title>
<![CDATA[
A Cross-Sectional Analysis of Depression and Anxiety Symptoms in the US National Health Interview Survey 2022: A Descriptive Focus on the Black-Latine Community 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26361644v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo describe the prevalence of anxiety and depression symptoms among Black-Latines compared to other racial/ethnic groups in the United States.

MethodsThis cross-sectional analysis leveraged data from the 2022 National Health Interview Survey (NHIS) to estimate the prevalence of anxiety and depression as measured by the GAD-7 and PHQ-8, respectively. Anxiety and depression scores in Black-Latine were compared to White-Latine, Non-Latine White, and Non-Latine Black respondents.

ResultsBlack-Latines were more likely to score higher on both the GAD-7 and PHQ-8 indicating higher prevalence of more than minimal anxiety (22.0%) and more than minimal depression (26.0%) than both Non-Latine Black, anxiety (18.0%) and depression (22.0%), and White-Latine, anxiety (16.0%) and depression (18.0%), respondents.

ConclusionsBlack-Latines are more likely to report more depression and anxiety symptoms than their Non-Latine Black and White-Latine counterparts. Studies should try to disaggregate Black subgroups in order to identify the most vulnerable populations.
]]></description>
<dc:creator><![CDATA[ Allen, E. D., Di Giuseppe, E. C., Cruz, M., Christie, S., Abdiwahab, E., Mehta, K. M. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26361644</dc:identifier>
<dc:title><![CDATA[A Cross-Sectional Analysis of Depression and Anxiety Symptoms in the US National Health Interview Survey 2022: A Descriptive Focus on the Black-Latine Community]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.28.26364154v1?rss=1">
<title>
<![CDATA[
How much is enough? Optimising sampling frames for genomic surveillance of Escherichia coli and Klebsiella spp. bloodstream infections - a retrospective study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364154v1?rss=1
</link>
<description><![CDATA[
BackgroundOptimising sampling frames for genomic surveillance of E. coli and Klebsiella may support interventions to mitigate bloodstream infections (BSIs), but approaches to estimating sample size and how these relate to bacterial population diversity at multiple genetic levels (strain/plasmid/antimicrobial resistance genes [ARGs]) are lacking.

MethodsUsing systematically collected, regionally-stratified, whole genome sequencing data from a 6-month genomic survey of English E. coli/Klebsiella BSI isolates (n=1,939; NEKSUS), we used Bayesian approaches to estimate the sample sizes required to capture genetic diversity at strain-(MLST, fastBAPS clusters), plasmid- and ARG-levels, using two diversity measures:  coverage (i.e. proportion of the bacterial population/plasmids/ARGs represented by features observed in the sample), and the number/proportion of unique features observed at varying surveillance sample sizes. Our method is available as a user-friendly R Shiny application, EpiSENTRY (https://01a0c3dd-90d2-e597-58a5-51391a468387.share.connect.posit.cloud/).

FindingsRandomly sampling 1,400 E. coli/Klebsiella BSI isolates each achieved [&ge;]80% coverage of bacterial lineages and ARGs (i.e. capture features constituting [&ge;]80% of the population) at 95% certainty, but captured lower proportions of unique features (28% MLSTs, 59% fastBAPS clusters, 19% plasmid subcommunities, and 57% ARGs for E. coli; 49%, 87%, 50% and 83% for Klebsiella, respectively). Sample sizes required for 80% coverage of E. coli plasmid populations were higher than MLSTs (1,928[95% CrI:1,837-2,025] vs 1,351[1,230-1,472]), while for Klebsiella, estimates were lower for plasmids (1,115[1,052-1,181] vs 1,422[1,331-1,515] for MLSTs). Lower sample sizes adequately captured 80% coverage of fastBAPS clusters and ARGs (649[575 - 727] and 27[23-30], respectively, for E. coli; 113[84-145] and 83[72-96] for Klebsiella), due to feature-specific frequency distributions. Klebsiella BSIs were more diverse than E. coli, with sampling 10.9% vs 3.2% of total annual BSIs in England needed to reach 80% MLST coverage. Plasmid populations and Klebsiella MLSTs were region-specific, emphasising the need for regionally-representative sampling.

InterpretationBayesian analysis facilitates estimates of context-specific genomic surveillance sample sizes. Cost-effective targets for coverage require further optimisation.

FundingNational Institute for Health and Social Care Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance (NIHR207397); UKHSA and NIHR Oxford Biomedical Research Centre (BRC); UKHSA PhD Funding Competition; Robertson Fellowship; cloud compute infrastructure for this work was donated by Oracle Corporation Infrastructure.

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSA MEDLINE (Ovid) search for genomic surveillance sample size estimation ("sample size estimation/calculation" AND "surveillance"; no restrictions on publication type, date or language) retrieved 62 records (22 included). Most studies (68% [15/22]) used calculations based on frequentist formulae, which require a user-specified arbitrary minimum frequency threshold for the feature/disease under surveillance. Surveillance outcomes were mostly prevalence/incidence (59% [13/22]) and presence/absence (54% [12/22]) of diseases/genomic features, and all studies considered diseases/features individually. Re-analyses of COVID-19 variant surveillance in high-income settings suggested that one third of the sequencing effort would have sufficed. Several publications highlight estimates should be tailored to specific surveillance goals. No studies extended surveillance sample size calculations to capturing population diversity of multiple genomic features simultaneously (e.g. plasmids, antimicrobial resistance [AMR] genes [ARGs]), although these may be important for bacterial genomic surveillance.

Bayesian estimation is a powerful method of statistical inference where prior beliefs about the distribution of a population parameter (e.g.: the frequency of a certain genomic feature) can be updated to a more realistic posterior distribution using the likelihood of the available data, thus incorporating uncertainty from potentially noisy data.

Added value of this studyWe applied Bayesian analysis to large-scale genomic data from a 6-month nationally-representative survey of English bloodstream infection-associated E. coli and Klebsiella to estimate the posterior frequency distribution, with uncertainty, of four genomic features (multi-locus sequence type [MLST], fastBAPS cluster, plasmid subcommunities, ARGs). We used estimates to inform meaningful minimum feature frequency thresholds for conventional sample size calculations, by relating frequency to proportion of population diversity captured (i.e.: coverage - the proportion of the population represented by the features detected at least once in the sample), as well as number/proportion of unique features captured. This method overcomes limitations of ecological estimators when scaling to large populations by using all survey data to inform estimates, while placing more weight on epidemiologically important common features. We have made our method available as a user-friendly R Shiny application, EpiSENTRY (https://01a0c3dd-90d2-e597-58a5-51391a468387.share.connect.posit.cloud/), allowing users to easily estimate sample sizes from their own data.

Implications of all the available evidenceRandomly sampling 1,400 E. coli and Klebsiella bloodstream (BSI) isolates, each, in England sufficiently captured strains and ARGs representing 80% of the estimated total bacterial population (80% coverage) at 95% certainty. While this captured the most common BSI-associated bacterial genomic features, >51% of unique MLSTs, >50% of plasmid subcommunities, >13% of fastBAPS clusters, and >17% of ARGs may remain undetected even at high coverages because there are so many unique variants at all genomic levels. Target coverage thresholds may need to be adjusted, or alternative targeted sequencing methods used (e.g. selection based on phenotype) for rare features of critical public health importance (e.g. carbapenemases). Klebsiella BSIs were more diverse than E. coli, relative to incidence, requiring 10.9% vs 3.2% of BSIs to be sequenced to capture comparable diversity. Plasmid populations and Klebsiella MLSTs were also region-specific, emphasising the need for regionally-representative sampling. Sample size estimates should be context-specific to best support national, regional, or local surveillance, and potentially inform infection prevention and control (IPC) efforts. Cost-effectiveness analyses are required to optimise sampling strategies.
]]></description>
<dc:creator><![CDATA[ Nagy, D., The NEKSUS Consortium,, Hopkins, S., Crook, D., Walker, A. S., Robotham, J. V., Hopkins, K. L., Ledda, A., Wilson, D. J., Williams, D., Hope, R., Brown, C. S., Stoesser, N., Lipworth, S. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.28.26364154</dc:identifier>
<dc:title><![CDATA[How much is enough? Optimising sampling frames for genomic surveillance of Escherichia coli and Klebsiella spp. bloodstream infections - a retrospective study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.28.26364096v1?rss=1">
<title>
<![CDATA[
Validity and reliability of the Japanese version of the Movement Behaviour Questionnaire-Child (MBQ-C) for assessing active play, screen time, and sleep in preschool children 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.28.26364096v1?rss=1
</link>
<description><![CDATA[
BackgroundValid and feasible measures of preschoolers 24-hour movement behaviours are needed for population-level research. We developed a Japanese version of the Movement Behaviour Questionnaire-Child (MBQ-C) and evaluated its measurement properties and practicality.

MethodsAfter translation and cross-cultural adaptation following the COSMIN procedure, including cognitive interviews, we evaluated the questionnaire in a cross-sectional validation study of Japanese children aged 3-6 years. Concurrent validity was assessed against hip-worn accelerometry and a 7-day diary; we also examined test-retest reliability, measurement error, agreement between response formats and modes, and practicality (completion time, burden, and clarity). Analyses used Spearman correlations, intraclass correlation coefficients, the SEM, smallest detectable change (SDC), and Wilcoxon signed-rank tests.

ResultsOf 208 children, 170 provided valid accelerometer and diary data for the concurrent-validity analysis, and 187 completed the MBQ-C for the questionnaire-based analyses. Concurrent validity was weak for active and energetic play (Spearman {rho} = 0.12-0.26), strong for total screen time (0.78-0.85), and moderate for total sleep (0.48-0.58). Test-retest reliability was moderate to good (ICC, 0.66-0.81), and within-child variability was lowest for sleep (CV 3%) and highest for the physical activity items (21-33%). The open- and closed-ended versions showed no significant differences; paper-electronic agreement was good for screen time and sleep but poor for active play. Completion took approximately 6-9 minutes, with low reported burden. Findings were robust in sensitivity analyses. At the group level, SDC for a mean was SDCind/{surd}N: 119.8/{surd}N, 74.0/{surd}N, 112.6/{surd}N, and 92.5/{surd}N min/day for active play, energetic play, total screen time, and total sleep, respectively (N = number of children surveyed). The systematic differences between the two test-retest occasions were +15.7, +6.5, +4.0, and -5.4 min/day, respectively.

ConclusionsThe Japanese MBQ-C is a practical option for assessing preschoolers active play, screen time, and sleep at the group level. By quantifying its group-level measurement error, this study provides benchmarks for interpreting group-level differences and change, supporting the use of the MBQ-C in surveillance and evaluation of programmes delivered at scale.
]]></description>
<dc:creator><![CDATA[ Komura, K., Yamakita, M., Kyan, A., Inoue, S., Nagano, M., Takenaga, R., Breugelmans, R., Jego, E. H., Trost, S. G. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.28.26364096</dc:identifier>
<dc:title><![CDATA[Validity and reliability of the Japanese version of the Movement Behaviour Questionnaire-Child (MBQ-C) for assessing active play, screen time, and sleep in preschool children]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.22.26363661v1?rss=1">
<title>
<![CDATA[
Forecasting global progress towards the United Nations hypertension control target for 2030 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.22.26363661v1?rss=1
</link>
<description><![CDATA[
In 2025, the United Nations General Assembly adopted a target of 150 million additional people with hypertension under control by 2030, but did not specify the baseline year. We quantified how baseline choice affects estimated progress towards this target and forecast the number of adults with controlled hypertension globally through 2030. Age- and sex-specific hypertension prevalence and control estimates from the NCD Risk Factor Collaboration for 1990-2019 were combined with United Nations World Population Prospects 2024 for adults aged 30-79 years in 200 countries and territories. Bayesian state-space models generated separate prevalence and control forecasts, propagated through 100 000 posterior draws. We evaluated baselines of 2020, 2023, 2024 and 2025 and decomposed the 2024-2030 change using continuous-change decomposition. Holding the 2030 forecast constant, estimated target attainment ranged from 94.4% with a 2020 baseline to 51.4% with a 2025 baseline. Using the prespecified 2024 baseline, the number of adults with controlled hypertension was forecast to increase from 332.4 million in 2024 to 423.9 million in 2030, an increase of 91.5 million (95% uncertainty interval 75.2-110.0 million), corresponding to 61.0% (95% uncertainty interval 50.2-73.3%) of the target and a median shortfall of 58.5 million. The control-rate improvement component accounted for 66.3% of the increase and demographic change for 44.0%, while declining age-sex-specific hypertension prevalence offset 10.4%. Progress towards this absolute target cannot be interpreted unambiguously without an explicit baseline year. From a 2024 baseline, current forecast trajectories fall short of the 2030 target.
]]></description>
<dc:creator><![CDATA[ Carniel, T. A., Manica, A., Strobel Neto, W., Pinheiro, E., Lutinski, J. A., Ferretti, F. K., Zuge, S. S., Trindade, L. d. L., De Sa, C. A. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.22.26363661</dc:identifier>
<dc:title><![CDATA[Forecasting global progress towards the United Nations hypertension control target for 2030]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.29.26364257v1?rss=1">
<title>
<![CDATA[
COMMUNITY KNOWLEDGE AND ATTITUDE TOWARDS POLIO IMMUNIZATION IN NORTHERN NIGERIA 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.29.26364257v1?rss=1
</link>
<description><![CDATA[
BackgroundPoliomyelitis remains a major public health concern where population immunity is incomplete and circulating vaccine-derived poliovirus (cVDPV) persists. Although Nigeria interrupted wild poliovirus (WPV) transmission in 2020, cVDPV cases continue to pose challenges, particularly in parts of northern Nigeria. Modern control strategies require a synergy of routine immunization, supplementary campaigns, disease surveillance, and community trust.

MethodsThis multicentre descriptive cross-sectional study evaluated community knowledge and attitudes towards polio immunization across 37 Local Government Areas (LGAs) in 20 states and the Federal Capital Territory (FCT). A multistage sampling strategy was utilized to select 1,850 adult respondents (50 per LGA) spanning rural, semi-urban, and urban settlements.

ResultsOverall, 40.4% (n = 747) of respondents demonstrated good knowledge, while 58.4% (n = 1,080) displayed positive attitudes towards polio immunization. A striking disparity was observed across residence classifications: respondents in urban/semi-urban LGAs exhibited significantly higher levels of good knowledge (51.7%, 569/1,100) compared to those in rural LGAs (23.7%, 178/750; {chi}2 = 144.00, df = 1, p < 0.001). Main sources of information were Questionnaire responses (53.6%) and community and Traditional leaders(17.2%).

Conclusion & RecommendationsSubstantial knowledge deficits persist in rural northern Nigerian communities despite generally favorable attitudes. Interventions must prioritize localized risk communication, involvement of traditional/religious leaders, strengthening routine primary healthcare integration, and targeting zero-dose children in hard-to-reach areas.
]]></description>
<dc:creator><![CDATA[ Muhammad, A. G., Abar, I. O., Sule, H., Olim, A. N. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.29.26364257</dc:identifier>
<dc:title><![CDATA[COMMUNITY KNOWLEDGE AND ATTITUDE TOWARDS POLIO IMMUNIZATION IN NORTHERN NIGERIA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26362980v1?rss=1">
<title>
<![CDATA[
Early Pregnancy Glycosylated Hemoglobin in Relation to Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Evidence from a Multisite Low- and Middle-Income Countries Cohort 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26362980v1?rss=1
</link>
<description><![CDATA[
BackgroundOral glucose tolerance test (OGTT), the gold standard for diagnosing gestational diabetes mellitus (GDM), faces significant implementation challenges, prompting interest in alternative biomarkers, such as glycated hemoglobin (HbA1c), for early detection. This study aimed to assess the association between early pregnancy HbA1c and subsequent GDM and adverse perinatal outcomes in low- and middle-income countries.

MethodsWe analyzed data from the Pregnancy Risk, Infant Surveillance, and Measurement Alliance - Maternal and Newborn Health (PRISMA-MNH) cohort, which followed pregnant women enrolled before 20 weeks of gestation across five study sites in Kenya, India, Pakistan, and Zambia. We excluded participants with overt diabetes, severe anemia (Hb <7.0 g/dl), multiple gestations, or pregnancies that ended before 24 weeks of gestation. HbA1c was measured at enrollment. The primary outcome was GDM, diagnosed according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria based on OGTT performed after 24 weeks of gestation. Secondary outcomes included hypertensive disorder of pregnancy, emergent Cesarean section, preterm birth, large for gestational age, and stillbirth after 28 weeks. We used AUC and ROC analyses to evaluate predictive performance and single- and two-threshold approaches to identify optimal cutoffs for predicting GDM. We used modified Poisson regression with robust standard errors to assess associations between early HbA1c and outcomes, and meta-analysis to pool site-specific estimates.

ResultsAmong 10,918 pregnancies, GDM prevalence was 6.4%. Women with GDM were older (28.0{+/-}5.4 versus 26.0{+/-}5.3 years) and had higher BMI at enrollment (25.0{+/-}5.8 versus 22.9{+/-}5.0 kg/m2) than women without GDM. The AUC for HbA1c alone in predicting GDM was 0.65 (95% confidence interval 0.63-0.67). A single early HbA1c threshold of 5.4%, based on the largest Youdens index, showed limited predictive performance (sensitivity 46.7%, specificity 75.8%). A two-threshold approach identified rule-out and rule-in cutoffs of 5.0% (sensitivity 80.3%, specificity 35.6%) and 5.5% (sensitivity 34.5%, specificity 83.1%), respectively. In adjusted models, each 0.1% increase in HbA1c was associated with a 12% higher risk (RR 1.12, 95% CI 1.10-1.15) of GDM, while no significant associations were observed for any secondary outcomes.

ConclusionEarly pregnancy HbA1c is independently associated with an increased risk of subsequent GDM. However, it demonstrated limited discriminatory ability as a standalone alternative to OGTT for identifying women who would later develop GDM. The identified rule-out threshold may help identify women at low risk of GDM, although the majority would still require OGTT for definitive diagnosis.
]]></description>
<dc:creator><![CDATA[ Yang, W.-C., Sunil Joseph, S., Vijayalekshmi, B., Freeman, B. L., Nisar, M. I., Pan, Q., Benjamin, S. J., G, J. A., Sharma, N., Mazumder, S., Hoodbhoy, Z., Akelo, V., Aweyo, F., Smith, E. R., Mores, C. N., Oakley, E. M., Spelke, M. B., Mwape, H., Mukuka, S., Kasaro, M. P., Cherian, A. G. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26362980</dc:identifier>
<dc:title><![CDATA[Early Pregnancy Glycosylated Hemoglobin in Relation to Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Evidence from a Multisite Low- and Middle-Income Countries Cohort]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26363779v1?rss=1">
<title>
<![CDATA[
Clinically Recognised Alcohol Use Disorder and Risk of Dementia Subtypes in 1.3 Million Women: A Prospective Cohort Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363779v1?rss=1
</link>
<description><![CDATA[
Background: Alcohol use disorder (AUD) is associated with increased dementia risk, but its long-term relationship with dementia, variation by age and subtype, and how this risk compares with that associated with alcohol consumption remain poorly characterised. We investigated these questions in a large prospective cohort of UK women. Methods: We analysed Million Women Study participants recruited aged 50-64 years and followed for more than 20 years through linked health records. Women with hospital-recorded AUD were matched to up to five controls. Cox models estimated associations between time-varying AUD and incident dementia overall, by subtype and attained age, with exposure lags of up to 15 years and competing-risk analyses. Self-reported alcohol consumption was analysed separately. Findings: Among 1,288,359 women, 20,070 with AUD were matched to 100,339 controls. Dementia occurred in 3,774 women with AUD and 8,239 matched controls. AUD was associated with all-cause dementia (HR=3.73 [95% CI 3.52-3.95]), with strongest associations for mixed (5.03 [3.88-6.51]), unspecified (4.29 [3.92-4.70]), and vascular dementia (3.96 [3.44-4.56]). Associations were substantially stronger before age 70 years (10.68 [9.02-12.63]) than at ages 70-79 years (3.75 [3.47-4.04]) or 80 years or older (2.34 [2.11-2.60]). Risk remained elevated with a 15-year lag (2.16 [1.81-2.58]) and after accounting for competing mortality. Associations with self-reported alcohol consumption were substantially weaker. Interpretation: Clinically recognised AUD identifies women at markedly increased and prolonged dementia risk, particularly at younger ages and for vascular and mixed dementia, not captured by drinking quantity alone. People with AUD should be considered a priority population for earlier dementia prevention and risk reduction. Funding: Wellcome Trust Career Development Award to AT (306069/Z/23/Z); NIH grants P50AA012870 and R01DA054869 (JG). The Million Women Study is supported by the UK Medical Research Council (grant number UKRI1464).
]]></description>
<dc:creator><![CDATA[ Fatih, N. G., Hippisley-Cox, D., Ebmeier, K. P., Gelernter, J., Reeves, G. K., Floud, S., Christodoulou, M. D., Topiwala, A. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26363779</dc:identifier>
<dc:title><![CDATA[Clinically Recognised Alcohol Use Disorder and Risk of Dementia Subtypes in 1.3 Million Women: A Prospective Cohort Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.24.26363961v1?rss=1">
<title>
<![CDATA[
Adult disability and mental/psychological illness in Somaliland socioeconomic inequalities and co-occurrence in the 2020 Somaliland Health and Demographic Survey 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.24.26363961v1?rss=1
</link>
<description><![CDATA[
Disability is an important population-health concern, but adult-specific evidence on its distribution and socioeconomic patterning remains limited in Somaliland. This study estimated the prevalence and distribution of reported disability among adults in Somaliland and examined socioeconomic inequality, reported mental/psychological illness, and their co-occurrence.

We conducted a cross-sectional secondary analysis of the 2020 Somaliland Health and Demographic Survey. The analysis included 14,579 adults aged [&ge;]18 years who were usual residents, had the disability module administered, and had a defined reported mental/psychological illness measure. Reported disability was defined as at least one positive response across seven disability domains: sight, hearing, speech, learning, mobility, self-care, and mental. Survey-weighted prevalence estimates and design-based comparisons were calculated. Survey-weighted logistic regression assessed associations with household wealth and other covariates. Socioeconomic inequality was assessed using a concentration index and the normalized Erreygers concentration index. Co-occurrence was evaluated by comparing observed joint prevalence with that expected under statistical independence and by survey-weighted logistic regression.

The survey-weighted prevalence of any reported disability was 7.30% (95% CI 6.65-8.02). Sight was the most frequently reported domain (3.83%, 95% CI 3.19-4.59), followed by hearing (1.54%, 95% CI 1.20-1.97) and mobility (1.39%, 95% CI 1.14-1.70). Disability prevalence increased markedly with age, from 4.15% among adults aged 18-29 years to 23.96% among those aged [&ge;]60 years. The crude wealth pattern was non-monotonic and was not statistically detectable after adjustment for residence and region. The concentration index for reported disability was 0.0584 (SE 0.0284, p=0.0415). Reported mental/psychological illness had a weighted prevalence of 0.71% (95% CI 0.50-1.00). Both reported disability and reported mental/psychological illness occurred in 0.5032% of adults, compared with 0.05185% expected under statistical independence; the observed-to-expected ratio was 9.70 (95% CI 7.60-11.81). After adjustment for age group and sex, reported disability was strongly associated with reported mental/psychological illness (OR 42.99, 95% CI 18.45-100.18).

Reported disability affected approximately one in fourteen adults in Somaliland and showed a marked age gradient and substantial geographic variation. The crude socioeconomic pattern was attenuated after adjustment for geographic context, while concentration analysis indicated modest marginal concentration toward higher wealth ranks. Reported mental/psychological illness was uncommon but co-occurred with reported disability more often than expected under independence. These findings provide an adult population baseline for Somaliland while highlighting the need to distinguish survey-reported disability from the separate mental/psychological illness construct and to interpret the findings within the limitations of cross-sectional, survey-reported measures.

Author Summary Why was this study done?O_LIEvidence on disability among adults in Somaliland is limited, especially on its socioeconomic distribution and relationship with reported mental/psychological illness.
C_LIO_LIWe used the 2020 Somaliland Health and Demographic Survey to examine these patterns nationally.
C_LI

What did the researchers do and find?O_LIWe analysed 14,579 adults aged 18 years or older using survey-weighted methods that accounted for the surveys sampling design.
C_LIO_LIOverall, 7.30% of adults reported at least one disability domain. Sight, hearing, and mobility were most frequently reported, and disability was much more common among older adults and varied across regions and residence settings.
C_LIO_LIReported mental/psychological illness was found in 0.71% of adults. Both conditions occurred together in 0.50%, substantially more than expected under statistical independence.
C_LI

What do these findings mean?O_LIOur study provides an adult population baseline for reported disability in Somaliland and shows clear differences by age and geographic context.
C_LIO_LIOur findings highlight the importance of keeping reported disability and reported mental/psychological illness as distinct measures.
C_LIO_LIBecause our data are cross-sectional and based on reported survey measures, the findings describe the 2020 survey period and do not establish clinical diagnoses or causal relationships.
C_LI
]]></description>
<dc:creator><![CDATA[ Saed, A. A., Osman, O. A., Adan, A. M., Suleiman, Y. I., Mohamed, A. I. ]]></dc:creator>
<dc:date>2026-09-29</dc:date>
<dc:identifier>doi:10.64898/2026.09.24.26363961</dc:identifier>
<dc:title><![CDATA[Adult disability and mental/psychological illness in Somaliland socioeconomic inequalities and co-occurrence in the 2020 Somaliland Health and Demographic Survey]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.25.26363991v1?rss=1">
<title>
<![CDATA[
Timing matters: when do primiparous and multiparous pregnant women initiate folic acid supplementation, and who initiates it too late? 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.25.26363991v1?rss=1
</link>
<description><![CDATA[
BackgroundWomen are recommended to take folic acid supplements (FAS) periconceptionally to prevent neural tube defects, but the low levels of FAS uptake are poorly understood. This study aimed to determine how parity, pregnancy planning and other maternal factors affect the timing of FAS initiation.

MethodWe used data from a representative sample of 966 pregnant women from the Northern Ireland Baby Hearts study. Questionnaire responses on health behaviours, including FAS, were linked to maternity and area-based deprivation data. Logistic regression assessed determinants of FAS initiation preconception. Time-varying Cox regression assessed associations between initiation postconception and pregnancy-related milestones.

ResultsForty-one per cent of women initiated FAS preconception. Lower odds of preconception initiation were associated with multiparity (adjusted OR 0.47 (0.32 - 0.68)), unplanned pregnancy (adjusted OR 0.08 (0.05 - 0.13)), deprivation and consuming a low folate diet. Higher odds were associated with fertility treatment and previous pregnancy loss. Forty-seven per cent of women initiated FAS postconception, mainly after pregnancy recognition (median 5 weeks), including 34.1% of those who planned their pregnancy. For primiparous women with unplanned pregnancies, the first health service contact (median 7 weeks) further increased FAS initiation.

ConclusionMany women, even multiparous women with previous pregnancy experience and women who planned their pregnancies, are initiating FAS after pregnancy recognition. This shows awareness of FAS benefits, but is too late to prevent neural tube defects. Public health interventions need to go beyond awareness to address motivation and opportunity for FAS, and pay more attention to multiparous women.
]]></description>
<dc:creator><![CDATA[ Ebong, U., Given, J., Casey, F., Loane, M., Dolk, H. ]]></dc:creator>
<dc:date>2026-09-27</dc:date>
<dc:identifier>doi:10.64898/2026.09.25.26363991</dc:identifier>
<dc:title><![CDATA[Timing matters: when do primiparous and multiparous pregnant women initiate folic acid supplementation, and who initiates it too late?]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.24.26363829v1?rss=1">
<title>
<![CDATA[
Alternative PFAS Are Associated with Ovarian Cancer-Related Lipidomic Remodeling and Cross-Matrix Metabolic Signatures 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.24.26363829v1?rss=1
</link>
<description><![CDATA[
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants with the potential to disrupt metabolic processes and contribute to carcinogenesis; however, molecular evidence linking alternative and emerging PFAS to ovarian cancer (OC) remains limited. We conducted a biomarker-based case-control study integrating exposureomics with multi-omics profiling. Plasma samples from 128 patients with OC and 128 controls were analyzed for 26 PFAS, untargeted metabolomics, lipidomics, and clinical phenotypes, while urine samples from an additional 100 patients and 100 controls underwent untargeted metabolomic and clinical profiling. Single-compound, burden-based, and mixture models were integrated with PFAS-omics association scans, cross-matrix metabolite prioritization, observational exposure-omics-clinical association-chain analyses, and repeated internal cross-validation. Higher PFAS burdens were consistently associated with OC case status, and DONA, GenX, PFNA, PFPeS, PFUdA, and PFTrDA constituted an OC-prioritized six-PFAS mixture. DONA and GenX exhibited the broadest lipid-related bridging signals, particularly across phospholipids, lysophospholipids, sphingolipids, neutral lipids, and acylcarnitines. Integrated plasma and urine analyses further identified five shared metabolites--elaidic acid, hippuric acid, betaine, corticosterone, and taurocholic acid--that provided incremental and complementary discrimination beyond reference models based on clinical variables and tumor markers in internal cross-validation. Collectively, these findings demonstrate that both alternative and emerging PFAS are associated with a distinct OC-related molecular phenotype involving coordinated lipidomic, metabolomic, and hematologic alterations, while highlighting DONA and GenX as the most prominent exposure-related signals.

Highlights* First epidemiologic evidence linked DONA and GenX to OC-related lipid remodeling.

* Single-compound, class-burden, and mixture models consistently linked PFAS to OC.

* Plasma-urine integration yielded a Core-5 signature beyond clinical markers.

* PFAS-omics-clinical networks highlighted lipid modules and RDW-SD phenotypes.
]]></description>
<dc:creator><![CDATA[ Liu, H., Ni, J., Gao, N., Zhang, C., Li, X., Jiang, N., Wang, S., Chen, X. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.24.26363829</dc:identifier>
<dc:title><![CDATA[Alternative PFAS Are Associated with Ovarian Cancer-Related Lipidomic Remodeling and Cross-Matrix Metabolic Signatures]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.22.26363747v1?rss=1">
<title>
<![CDATA[
Epidemiological patterns and factors associated with mortality among diphtheria cases in Kano State, Nigeria (2022-2025): A retrospective cohort study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.22.26363747v1?rss=1
</link>
<description><![CDATA[
IntroductionNigeria continues to report one of the highest burdens of diphtheria globally, with Kano State accounting for a disproportionate share of cases and deaths. Understanding epidemiological patterns and mortality determinants is essential for guiding targeted interventions.

ObjectivesTo describe the distribution of diphtheria cases in Kano State by socio-demographic and clinical characteristics, Local Government Area, and month of reporting, and identify independent predictors of mortality.

MethodsWe conducted a retrospective cohort study of 21,369 patients with clinically compatible and laboratory-confirmed diphtheria using secondary data from medical records (2022-2025). Descriptive statistics summarized patient characteristics and disease distribution. Associations with mortality were assessed using chi-square or Fishers exact tests. Multivariable logistic regression identified predictors of mortality, reported as adjusted odds ratios (aORs) and 95% confidence intervals (CIs).

ResultsOf 21,369 patients, 13,557 (63%) were female, with a median age of 11 years (IQR: 7-13.6). Children aged 5-9 years accounted for 29% of cases. Prior contact with a case was reported in 2,633 (12%) patients, while 168 (1%) were laboratory-confirmed. Overall, 13,468 (63%) patients were unvaccinated and 5,381 (25%) fully vaccinated; Diphtheria antitoxin DAT was administered to 2,035 (10%). Cases occurred in all local government areas (LGAs), with four accounting for 60% of cases. Transmission occurred year-round, peaking in March 2024 and August 2023 and 2025. Overall, 1,131 deaths occurred (CFR: 5.3%). Compared with patients aged [&ge;]20 years, younger age groups had higher odds of mortality: 0-4 years (aOR = 26.74, 95% CI: 17.64-42.72), 5-9 years (aOR = 19.77, 95% CI: 13.17-31.33), 10-14 years (aOR = 8.21, 95% CI: 5.41-13.13), and 15-19 years (aOR = 2.46, 95% CI: 1.45-4.26). Prior contact with a case was associated with lower odds of mortality (aOR = 0.42, 95% CI: 0.30-0.55), whereas laboratory confirmation (aOR = 2.33, 95% CI: 1.48-3.56) and DAT receipt (aOR = 2.55, 95% CI: 2.19-2.96) were associated with higher odds. Prior vaccination was associated with lower odds of mortality among fully vaccinated (aOR = 0.52, 95% CI: 0.44-0.61) and partially vaccinated patients (aOR = 0.61, 95% CI: 0.47-0.80).

Conclusions and recommendationsDuring the study period, diphtheria was more common among younger children, females, and the unvaccinated. Although concentrated in a few LGAs, transmission was widespread and varied seasonally. Mortality was associated with younger age, laboratory-confirmed infection, and use of diphtheria antitoxin, whereas vaccination and prior contact were protective. Reducing the burden requires sustained efforts to strengthen routine immunization, implement targeted vaccination campaigns, ensure early detection and prompt treatment, and improve contact tracing and case management.
]]></description>
<dc:creator><![CDATA[ Wekunda, P. W., Ogunbode, O., Okunromade, O. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.22.26363747</dc:identifier>
<dc:title><![CDATA[Epidemiological patterns and factors associated with mortality among diphtheria cases in Kano State, Nigeria (2022-2025): A retrospective cohort study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26363828v1?rss=1">
<title>
<![CDATA[
Prevalence and Associated Factors of Self-reported Domestic Elder Abuse among Rural Older Persons in Vietnam 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363828v1?rss=1
</link>
<description><![CDATA[
This study examined the prevalence of domestic elder abuse and examined factors in a province with a high aging index in Vietnam in 2025. Elder abuse was measured using the validated Vietnamese Domestic Elder Abuse Scale, covering psychological abuse, physical abuse, financial exploitation, neglect/abandonment. Logistic regressions identified factors associated with abuse. 29.44% of participants reported at least one abuse subtypes, with psychological abuse being the most common subtype (24.73%) and 9.82% experienced polyvictimization. Higher educational attainment was consistently associated with lower odds of all abuse subtypes. Having [&ge;]4 chronic conditions was associated with higher odds of psychological abuse compared with having none (OR= 2.79, 95%CI: 1.29-6.00). Difficulties in daily basic activities were associated with physical abuse (OR=5.42, 95%CI: 1.80-16.36), financial exploitation (OR=3.66, 95%CI: 1.34-10.01), and neglect/abandonment (OR=4.09, 95%CI: 1.72-9.70) compared with no difficulties. Findings highlight the need for stronger policy implementation and lifelong learning to prevent elder abuse in Vietnam.
]]></description>
<dc:creator><![CDATA[ DOAN, T. N. T., HOANG, V. H. T., GIANG, T. L., FANG, X., REIDY, D., GIANG, L. M. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26363828</dc:identifier>
<dc:title><![CDATA[Prevalence and Associated Factors of Self-reported Domestic Elder Abuse among Rural Older Persons in Vietnam]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26363803v1?rss=1">
<title>
<![CDATA[
Design and evaluation of a streamlined enrichment method for faster co-detection of enteric bacterial pathogens in natural soils and environmental samples 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363803v1?rss=1
</link>
<description><![CDATA[
This study developed a streamlined, sensitive and rapid method for co-detection of low concentrations of Salmonella enterica, Shigella flexneri, Listeria monocytogenes, and pathogenic Escherichia coli from soil. First, autoclaved soil from Iowa with serial dilutions of bacteria to confirm individual species recovery rates on selective agar by qPCR under varying primary enrichment times was used. All pathogens were detected by qPCR of colonies recovered from replicate sterile soils spiked with 10^1 or greater bacteria within 5 hours of enrichment. Shiga toxin expressing E. coli (STEC) and L. monocytogenes were consistently co-recovered in autoclaved and natural soil, pathogen spiking concentration, and secondary enrichment time. S.enterica was consistently recovered at autoclaved and natural concentrations, while S. flexneri detection rates fluctuated. Twenty-three soil samples from Kenyan neighborhoods, with prior evidence of contamination, was compared to qPCR detection at each protocol stage: processing, primary enrichment, secondary enrichment, and selective colony isolation. Detection rates substantially increased for S. enterica, STEC and other pathogenic E. coli after enrichment, with optimal detection rates occurring after secondary enrichment. Testing colonies from selective agar resulted in high false negative rates, possibly reflecting competition from native soil microbiota that was absent in spiked sterile soil experiment. Evaluation of the method with other environmental sample types yielded consistent detection patterns. Evidence suggests a protocol including 24-hour primary enrichment, followed by 24-hour secondary enrichment, and qPCR testing of soil DNA at primary and secondary steps is a reproducible and more expedient method for co-detecting common Enterobacteriaceae and L. monocytogenes pathogens in soil.
]]></description>
<dc:creator><![CDATA[ Madson, E., Kapanka, A., Kwamutakha, S., Ouma, C., Sinik, M., Okoth, B., Agira, J., Amondi, C., Simiyu, S., Gutema, F., Sewell, D., Baker, K. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26363803</dc:identifier>
<dc:title><![CDATA[Design and evaluation of a streamlined enrichment method for faster co-detection of enteric bacterial pathogens in natural soils and environmental samples]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.23.26363810v1?rss=1">
<title>
<![CDATA[
Rethinking seasonal COVID-19 vaccination in the endemic era: summer timing, eligibility, and frequency in the United States 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.23.26363810v1?rss=1
</link>
<description><![CDATA[
ImportanceWith a recent shift towards summer seasonal predominance of COVID-19 across much of the US, debate continues over optimal COVID-19 vaccination strategies regarding timing (including summer vaccination), eligibility, and dosing frequency. We evaluated the population-level impact of alternative vaccine strategies to inform US and state vaccine policy.

ObjectiveTo compare reductions in COVID-19 hospitalizations under different vaccination timing, eligibility, and dosing frequency.

DesignDecision analytical model using a stochastic individual-based model of SARS-CoV-2 transmission, calibrated to US COVID-19 hospitalization incidence from May 2024-April 2025.

SettingSimulated US national population, with additional scenarios representing state-level seasonal patterns.

ParticipantsSimulated population of 5 million individuals with US age structure, stratified by risk group (immunocompetent, high risk with comorbid conditions, or immunocompromised).

ExposuresVaccination timing, universal or age- and risk-based eligibility, and dosing frequency, including a hybrid strategy of universal annual vaccination with a second dose for adults [&ge;]65 years and immunocompromised adults (US vaccine policy during the study period).

Main Outcomes and MeasuresCOVID-19 hospitalization risk per 100,000 persons by age-risk group, measured among vaccinated individuals and in the total population.

ResultsIf summer COVID-19 vaccination timing is feasible, annual universal vaccination in July minimized risk (441 [95% UI: 423-463] COVID-19 hospitalizations per 100,000 persons among adults [&ge;]65 years) compared to a counterfactual scenario with no additional vaccination given during the study period (578 [553-601]). If timing does not change, hybrid vaccination minimized risk, followed by semiannual risk-based vaccination (460 [440-487] and 477 [454-499] hospitalizations per 100,000 in adults [&ge;]65 years, respectively). The advantage of summer timing diminished if vaccine coverage decreased by 5-10 absolute percentage points (25-50% relative decrease). The magnitude of benefit from summer-timed vaccination and semiannual doses in the highest-risk groups varied regionally.

Conclusions and RelevanceAlthough annual COVID-19 vaccination has historically been timed for winter transmission, summer vaccination may avert more hospitalizations if coverage is maintained, especially in states with predominantly summer transmission including Western and Southern states. The comparative impact of vaccination strategies, especially the benefit of a semiannual dose in the highest-risk groups, may vary regionally. COVID-19 vaccination timing and eligibility may warrant reconsideration.

Key pointsO_ST_ABSQuestionC_ST_ABSGiven increasing summer predominance of COVID-19 in the US, can changing the timing, eligibility, or dosing frequency of vaccination further reduce hospitalizations?

FindingsIn a decision analytical model calibrated to US COVID-19 hospitalization incidence, annual universal vaccination in July reduced hospitalization risk in adults [&ge;]65 years more than recently recommended hybrid vaccination (universal vaccination with a second dose in the highest-risk groups) with historical fall timing, provided historical vaccine coverage was maintained. The benefit from summer-timed and semiannual vaccination in the highest-risk groups varied regionally.

MeaningShifting COVID-19 vaccination to summer could further reduce hospitalizations, if coverage is maintained.
]]></description>
<dc:creator><![CDATA[ Bubar, K. M., Park, H. J., Bents, S. J., Tan, S. T., Singer, B. J., Kelly, J. D., Leon, T. M., Watt, J., Schechter, R., Lo, N. C. ]]></dc:creator>
<dc:date>2026-09-25</dc:date>
<dc:identifier>doi:10.64898/2026.09.23.26363810</dc:identifier>
<dc:title><![CDATA[Rethinking seasonal COVID-19 vaccination in the endemic era: summer timing, eligibility, and frequency in the United States]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.22.26363685v1?rss=1">
<title>
<![CDATA[
Age trajectories of infant mortality among Palestinian refugees born in 2010-2020: evidence from electronic health records 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.22.26363685v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo estimate age trajectories of infant mortality among Palestinian refugees using electronic health records, addressing the scarcity of reliable mortality data in forced displacement settings.

SettingPalestinian refugees living in Gaza, West Bank, Jordan, Syria and Lebanon.

DesignWe fitted a Bayesian Negative Binomial model to observed death counts, using a flexible parametric function (a shifting power function) to capture the shape of the infant mortality curve, across strata to infer age trajectories of infant mortality.

ParticipantsPalestinian refugees born in 2010-2020 and registered with UNRWA health services in Gaza, West Bank, Jordan, Syria and Lebanon. The sample was stratified by sex, field, gestational age and birth cohort.

Main outcome measuresSurvival rate to age 1.

ResultsOverall, the survival rate to age 1 was 98.64%, with slightly lower rates for males (98.57%) than females (98.68%). Across settings, West Bank refugees had the lowest infant mortality (99.08% survival rate), and Jordan refugees had the highest (98.22% survival rate). Results by gestational age showed a 98.85% survival rate at age 1 among term births compared to a 73.32% survival rate among very preterm births. Survival rates by cohort (births up to 2015 or after) were 98.78% and 98.42%, respectively.

ConclusionOur findings highlight the potential of electronic health records for mortality monitoring in forced displacement settings as they reveal consistent mortality trajectories by sex and gestational age, while identifying meaningful variation across refugee settings and subgroups.

Summary boxesO_ST_ABSWhat is already known in this topicC_ST_ABSWe searched PubMed and Google Scholar for articles published between Jan 1, 2000, and Feb 20, 2026, in English, using the terms "Palestinian refugees," "infant mortality," "neonatal mortality," and "UNRWA." We found a handful of studies estimating infant mortality among Palestinian refugees, mostly based on household surveys (eg, MICS, national statistical office surveys) or UNRWA surveys using preceding birth techniques. The preceding birth technique has notable limitations, including recall bias, small sample sizes, and selection bias. The majority of these studies focus exclusively on Palestinian refugees residing in Gaza. Estimates for Gaza suggest a sustained decline, from around 127 deaths per 1,000 births in 1960 to 20.2 per 1,000 births in 2006, with a slowdown thereafter and an increase in more recent years. A combined estimate (excluding Syria) across four settings where Palestinian refugees reside measures infant mortality at 18 per 1,000 births in 2011.

What this study addsThis study uses a unique data linkage bringing together UNRWAs obstetric and child health records, providing more extensive information and a larger sample size than previous studies. This is also the first study to assess the data quality of these electronic records and to estimate age trajectories of infant mortality among Palestinian refugees. We developed a statistical strategy that estimated infant mortality trajectories covering all five UNRWA fields (Gaza, Jordan, Lebanon, Syria, and the West Bank) for children born in 2010-2020, and examined differences across subpopulations by sex, field, gestational age and cohort.
]]></description>
<dc:creator><![CDATA[ Koksal, S., Chen, Y., Jamaluddine, Z., Akihiro, S., Checchi, F., Campbell, O., Aburto, J. M. ]]></dc:creator>
<dc:date>2026-09-23</dc:date>
<dc:identifier>doi:10.64898/2026.09.22.26363685</dc:identifier>
<dc:title><![CDATA[Age trajectories of infant mortality among Palestinian refugees born in 2010-2020: evidence from electronic health records]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.21.26363552v1?rss=1">
<title>
<![CDATA[
Unmasking digital despair: A language model framework for predicting depression on social media 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.21.26363552v1?rss=1
</link>
<description><![CDATA[
Depression is one of the most prevalent mental health disorders globally. Social media content can reflect emotional states, offering real-time signals of depressive symptoms. This study aimed to develop a deep learning model to predict depression using Twitter/X data, and to characterize potential causes of depression using a large language model (LLM). Twitter/X posts from April 20, 2023, to July 24, 2024, were obtained using the key phrase ("I" or "me") and "diagnosed with depression". After data cleaning and GPT-4o labelling, 2,275 depressive Twitter users, and an additional 1,661 non-depressive users from tweets using the keyword "today", were identified. A deep learning RoBERTa model for predicting depression was built on tweets from both user groups, with an 80/20 training-testing split. GPT-4o models were subsequently employed to analyze depressive users posts to understand potential causes for depression. The RoBERTa model achieved strong performance in predicting depression among Twitter users from their tweets, with an accuracy of 0.822, an F1 score of 0.855, and an AUC of 0.809. Common reasons for depression identified by GPT-4o models included societal pressure, low self-esteem, cultural influences, and identity-related challenges. These findings highlight the potential of deep learning models in early screening of depression using social media data. Insights into potential reasons for depression may inform targeted prevention strategies, public health interventions, and improved mental health support for at-risk populations.
]]></description>
<dc:creator><![CDATA[ Xie, M., He, H., Xie, Z. ]]></dc:creator>
<dc:date>2026-09-23</dc:date>
<dc:identifier>doi:10.64898/2026.09.21.26363552</dc:identifier>
<dc:title><![CDATA[Unmasking digital despair: A language model framework for predicting depression on social media]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.09.21.26363549v1?rss=1">
<title>
<![CDATA[
Objective peripheral neuropathy and protective-equipment use in a farming community in a lead-zinc mining district of south-eastern Nigeria: a cross-sectional study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.09.21.26363549v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo estimate the prevalence of objective peripheral neuropathy, and to test whether self-reported use of personal protective equipment (PPE) is associated with lower neuropathy risk, among adults attending a community hospital in a Nigerian population exposed to both agrochemicals and mining.

DesignClinic-based cross-sectional study (June-November 2025), reported per STROBE.

SettingInfant Jesus Community Hospital, Ishiagu, Ebonyi State, a community combining smallholder farming with granite and lead-zinc mining.

Participants285 adults ([&ge;]18 years) attending the outpatient screening department; people with known diabetes were excluded.

Main outcome measuresPeripheral neuropathy on the Michigan Neuropathy Screening Instrument (MNSI) examination -- an instrument validated in diabetic populations -- defined a priori as an abnormal 10 g monofilament test or absent/reduced ankle reflexes; three alternative case definitions were pre-specified. PPE use was scored 0-12. Associations were estimated by multivariable logistic regression adjusted for age and sex.

ResultsThe proportion screening positive was 47.0% (95% CI 41.2-52.8) under the primary definition and ranged from 29.8% to 56.8% across definitions. PPE use was near-absent (89.1% never used gloves; 43.2% used none) and showed no detectable protective association (adjusted OR 0.97 per point, 95% CI 0.88-1.06). Men used PPE more than twice as often as women (55.1% vs 24.5%, p<0.001), yet neuropathy did not differ by sex (41.6% vs 49.5%, p=0.27). Only age was associated with neuropathy (adjusted OR 1.02 per year, p=0.02).

ConclusionsNearly half of the adults sampled screened positive for peripheral neuropathy, and protective equipment showed no detectable protective association. Because PPE use was near-absent, the study cannot separate ineffective protection from too little protection to measure, and the cross-sectional design precludes causal inference. The equal burden across sexes despite markedly unequal protective behaviour is consistent with community-wide environmental exposure; reducing the total toxic load is a plausible priority that direct exposure measurement should now test.
]]></description>
<dc:creator><![CDATA[ Abanni, S. I., Adache, C., Ekure, B. M., Omotosho, J. ]]></dc:creator>
<dc:date>2026-09-23</dc:date>
<dc:identifier>doi:10.64898/2026.09.21.26363549</dc:identifier>
<dc:title><![CDATA[Objective peripheral neuropathy and protective-equipment use in a farming community in a lead-zinc mining district of south-eastern Nigeria: a cross-sectional study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
